BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18091744)

  • 1. Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits.
    Signolet IL; Bousquet PP; Monassier LJ
    Am J Hypertens; 2008 Jan; 21(1):54-60. PubMed ID: 18091744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiography in conscious 1K,1C Goldblatt rabbits reveals typical features of human hypertensive ventricular diastolic dysfunction.
    Signolet I; Gasser B; Bousquet P; Monassier L
    Int J Cardiol; 2009 Feb; 132(1):135-7. PubMed ID: 18045708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats.
    Li P; Huang PP; Yang Y; Liu C; Lu Y; Wang F; Sun W; Kong XQ
    J Appl Physiol (1985); 2017 Jan; 122(1):121-129. PubMed ID: 27742806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are centrally acting imidazoline agents appropriate therapy for renovascular hypertension?
    Head GA; Burke SL
    Ann N Y Acad Sci; 2003 Dec; 1009():234-43. PubMed ID: 15028593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E; Guimaraes DA; Ceron CS; Prado CM; Pinheiro LC; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2014 Aug; 73():308-17. PubMed ID: 24933619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic responses to stress and rilmenidine in 2K1C rabbits: evidence of enhanced nonvascular effector mechanism.
    Head GA; Burke SL
    Hypertension; 2004 Mar; 43(3):636-42. PubMed ID: 14744928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension.
    Burke SL; Evans RG; Head GA
    Br J Pharmacol; 2010 Jan; 159(2):438-48. PubMed ID: 20015085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac function in renovascular hypertensive patients with and without renal dysfunction.
    Khangura KK; Eirin A; Kane GC; Misra S; Textor SC; Lerman A; Lerman LO
    Am J Hypertens; 2014 Mar; 27(3):445-53. PubMed ID: 24162729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T; Shigematsu M
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
    Wang P; Tang F; Li R; Zhang H; Chen S; Liu P; Huang H
    Pharmacol Res; 2007 May; 55(5):408-17. PubMed ID: 17324585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac and renal baroreflex control during stress in conscious renovascular hypertensive rabbits: effect of rilmenidine.
    Burke SL; Head GA
    J Hypertens; 2009 Jan; 27(1):132-41. PubMed ID: 19145779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
    Amici E; Patruno N; Natale E; Marsocci A; Gambelli G
    Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.